Predictive factors of failure in management of ectopic pregnancy with single-dose methotrexate: A general population-based analysis from the Auvergne Register, France

Fertility and Sterility

Volumn 95, Issue 1, 2011, Pages

  Rabischong, Benoit ^a   Tran, Xavier ^a   Sleiman, Aline Abi ^a   Larraín, Demetrio ^a   Jaffeux, Patricia ^a   Aublet Cuvelier, Bruno ^a   Pouly, Jean Luc ^a   Fernandez, Hervé ^b  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

combined oral contraception; Ectopic pregnancy; general population; hCG level; learning curve; medical treatment; methotrexate failure

Indexed keywords

CHORIONIC GONADOTROPIN; METHOTREXATE; ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; DRUG TREATMENT FAILURE; ECTOPIC PREGNANCY; FEMALE; FRANCE; HUMAN; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; POPULATION BASED CASE CONTROL STUDY; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SINGLE DRUG DOSE;

EID: 78650415672     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2010.08.025     Document Type: Article

References (23)

1. J. Coste, J. Bouyer, S. Uguetto, L. Gerbaud, H. Fernandez, and J.L. Pouly Ectopic pregnancy is again on the increase. Recent trends in the incidence of ectopic pregnancies in France (1992-2002) Hum Reprod 19 2004 2014 2018
2. A.A. Luciano, G. Roy, and E. Solima Ectopic pregnancy from surgical emergency to medical management Ann N Y Acad Sci 943 2001 235 254
3. Practice Committee of the American Society for Reproductive Medicine Medical treatment of ectopic pregnancy Fertil Steril 90 Suppl 3 2008 S206 S212
4. N.M. van Mello, F. Mol, B.W. Mol, and P.J. Hajenius Conservative management of tubal ectopic pregnancy Best Pract Res Clin Obstet Gynaecol 23 2009 509 518
5. P.J. Hajenius, F. Mol, B.W. Mol, P.M. Bossuyt, W.M. Ankim, and F. van der Veen Interventions for tubal ectopic pregnancy Cochrane Database Syst Rev 1 2007 CD000324
6. F. Mol, B.W. Mol, W.M. Ankum, F. van der Veen, and P.J. Hajenius Current evidence on surgery, systemic methotrexate and expectant management in the treatment of tubal ectopic pregnancy: a systematic review and meta-analysis Hum Reprod Update 14 2008 309 319
7. P.J. Hajenius, S. Engelsbel, B.W. Mol, F. Van der Veen, W.M. Ankum, and P.M. Bossuyt Randomised trial of systemic methotrexate versus laparoscopic salpingostomy in tubal pregnancy Lancet 350 1997 774 779
8. H. Fernandez, C. Lelaidier, V. Thouvenez, and R. Frydman The use of a pretherapeutic, predictive score to determine inclusion criteria for the non-surgical treatment of ectopic pregnancy Hum Reprod 6 1991 995 998
9. M. Canis, D. Savary, J.L. Pouly, A. Wattiez, and G. Mage Ectopic pregnancy: criteria to decide between medical and conservative surgical treatment? J Gynecol Obstet Biol Reprod (Paris) 32 7 Suppl 2003 S54 S63
10. G.H. Lipscomb, M.L. McCord, T.G. Stovall, G. Huff, S.G. Portera, and F.W. Ling Predictors of success of methotrexate treatment in women with tubal ectopic pregnancies N Engl J Med 341 1999 1974 1978
11. M.B. Potter, L.A. Lepine, and D.J. Jamieson Predictors of success with methotrexate treatment of tubal ectopic pregnancy at Grady Memorial Hospital Am J Obstet Gynecol 188 2003 1192 1194
12. A. Nazac, A. Gervaise, J. Bouyer, R. de Tayrac, S. Capella-Allouc, and H. Fernandez Predictors of success in methotrexate treatment of women with unruptured tubal pregnancies Ultrasound Obstet Gynecol 21 2003 181 185
13. S. Dilbaz, E. Caliskan, B. Dilbaz, O. Degirmenci, and A. Haberal Predictors of methotrexate treatment failure in ectopic pregnancy J Reprod Med 51 2006 87 93
14. J. Coste, N. Job-Spira, B. Aublet-Cuvelier, E. Germain, E. Glowaczower, and H. Fernandez Incidence of ectopic pregnancy. First results of a population-based register in France Hum Reprod 9 1994 742 745
15. J. Coste, B. Aublet-Cuvelier, J. Bouyer, E. Germain, and N. Job-Spira Evaluation of the completeness of the Auvergne register of ectopic pregnancy with the capture-recapture method Rev Epidemiol Sante Publique 43 Suppl 1 1995 10
16. American College of Obstetricians and Gynecologists ACOG Practice Bulletin No. 94. Medical management of ectopic pregnancy Obstet Gynecol 111 2008 1479 1485
17. S. Menon, J. Colins, and K. Barnhart Establishing a human chorionic gonadotropin cutoff to guide methotrexate treatment of ectopic pregnancy: a systematic review Fertil Steril 87 2007 481 484
18. E. Nowak-Markwitz, M. Michalak, M. Olejnik, and M. Spaczynski Cutoff value of human chorionic gonadotropin in relation to the number of methotrexate cycles in the successful treatment of ectopic pregnancy Fertil Steril 92 2009 1203 1207
19. G.H. Lipscomb, K.J. Puckett, D. Bran, and F.W. Ling Management of separation pain after single-dose methotrexate therapy for ectopic pregnancy Obstet Gynecol 93 1999 590 593
20. T.G. Stovall, and F.W. Ling Single-dose methotrexate: an expanded clinical trial Am J Obstet Gynecol 168 1993 1759 1762
21. K.T. Barnhart, G. Gosman, R. Ashby, and M. Sammel The medical management of ectopic pregnancy: a meta-analysis comparing "single-dose" and "multidose" regimens Obstet Gynecol 104 2003 778 784
22. A. Alleyassin, A. Khademi, M. Aghahosseini, L. Safdarian, B. Badenoosh, and E.A. Hamed Comparison of success rates in the medical management of ectopic pregnancy with single-dose and multiple-dose administration of methotrexate: a prospective, randomized clinical trial Fertil Steril 85 2006 1661 1666
23. K.T. Barnhart, A.C. Hummel, M.D. Sammel, S. Menon, J. Jain, and N. Chakhtoura Use of "2-dose" regimen of methotrexate to treat ectopic pregnancy Fertil Steril 87 2007 250 256